having no symptoms or exhibiting abdominal symptoms
Conditions
Interventions
the group performing nasal breathing throughout the entire procedure
the group switching from nasal breathing to oral breathing after insertion at the esophageal entrance
Sponsors
Asahikawa Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 20 years or older at the time of consent. Patients who agree to undergo transnasal endoscopy. Patients who have provided written informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: Patients in whom transnasal endoscopy could not be inserted. Patients who wish to undergo sedation. Patients scheduled for endoscopic treatment. Patients who have undergone surgical resection of the upper gastrointestinal tract (esophagus, stomach, or duodenum). Patients who are unable to provide written informed consent to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| patient tolerance and endoscopist operability | — |
Secondary
| Measure | Time frame |
|---|---|
| patency of the upper to middle pharynx, endoscopic insertion time, and adverse events | — |
Countries
Japan
Contacts
Public ContactKeitaro TAKAHASHI
Asahikawa Medical University Gastroenterology
Outcome results
None listed